CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's disease

E. Brusamolino, G. Castelli, G. Pagnucco, E. Orlandi, D. Malago, M. Lazzarino, C. Bernasconi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)340-345
Number of pages6
Issue number4
Publication statusPublished - 1990

ASJC Scopus subject areas

  • Hematology

Cite this